Rhythm Pharmaceuticals Announces Preliminary Data from Exploratory Phase 2 Trial that showed Setmelanotide Demonstrated Positive Efficacy Signal in Prader-Willi Syndrome GlobeNewswire December 11, 2025 –– BMI and hyperphagia reductions have been observed in patients with PWS treated with setmelanotide at Month 3 (n=8) and Month 6 (n=5); 17 of 18 enrolled patients remain on therapy […]

Beneficient Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price GlobeNewswire December 11, 2025 DALLAS, Dec. 11, 2025 (GLOBE NEWSWIRE) — Beneficient (Nasdaq: BENF), a technology-enabled platform providing liquidity and related trust and custody services to holders of alternative assets, today announced a 1-for-8 reverse stock split (the “Reverse Stock Split”) of

Plus Therapeutics Expands CNSide Assay Platform to State of California CNSide Diagnostics now licensed in 48 U.S. States covering over 90% of the U.S. population GlobeNewswire December 11, 2025 HOUSTON, Dec. 11, 2025 (GLOBE NEWSWIRE) — CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical

Abeona Therapeutics(R) Announces New Qualified Treatment Center for ZEVASKYN(R) in Texas GlobeNewswire December 11, 2025 CLEVELAND, Dec. 11, 2025 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced activation of The University of Texas Medical Branch (UTMB) in Galveston, Texas, as the newest Qualified Treatment Center (QTC) for the administration of ZEVASKYN (prademagene zamikeracel)

BitMEX Debuts New Mobile Trading Experience With Intuitive Design and Controls GlobeNewswire December 11, 2025 VICTORIA, Seychelles, Dec. 11, 2025 (GLOBE NEWSWIRE) — BitMEX, one of the safest crypto exchanges, today announced significant upgrades to its mobile app, introducing a redesigned interface and new interaction model intended to support faster, clearer and more intuitive crypto

InflaRx Announces International Nonproprietary Name of “Izicopan” for INF904 GlobeNewswire December 11, 2025 JENA, Germany, Dec. 11, 2025 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the World Health Organization (WHO) has granted the international nonproprietary (generic) name (INN) of “izicopan” to

Autobahn Labs Forms Strategic Partnership with Astellas to Accelerate Academic Discoveries into New Medicines GlobeNewswire December 11, 2025 PALO ALTO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) — Autobahn Labs (“Autobahn”), a venture studio focused on transforming high-potential academic science into investable drug discovery and development programs, announced today a strategic partnership with global life sciences

Brink's Announces New $750M Share Repurchase Authorization GlobeNewswire December 11, 2025 RICHMOND, Va., Dec. 11, 2025 (GLOBE NEWSWIRE) — The Brink's Company (NYSE:BCO), a leading global provider of cash and valuables management, digital retail solutions “DRS”, and ATM managed services “AMS”, today announced the authorization of a new share repurchase program. Mark Eubanks, Brink's President

Americans report cutbacks and caution as tariffs threaten budgets and consumer confidence Over half of consumers (54%) have already cut back or plan to reduce their nonessential spending as a result of tariff-related price hikes, according to the results of a new survey byAchieve, the leader in digital personal finance. https://mma.prnewswire.com/media/2842713/achieve_tariff_study.jpg Tariffs are forcing tough

NEW YORK, NY / ACCESS Newswire / December 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Iron Mountain Incorporated ("Iron Mountain Incorporated") (NYSE:IRM) concerning possible violations of federal securities laws. On November 19, 2025, Gotham City Research published a report alleging that the company understates its leverage, inflates